Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 5/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6137518 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL2591054 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8418243 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8417908 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL1429079 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8417942 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8416746 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8417881 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8417889 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 | |
| SCHEMBL8419949 | 1.00 | KMT2A (0.43) | KMT2ASOAT1MEN1FAAHTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716874-B | Hydrophilic treatment-free plate protective adhesive and preparation method thereof | 安徽强邦新材料股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114716874-A | Hydrophilic treatment-free plate protective adhesive and preparation method thereof | 安徽强邦新材料股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-20250236990-A1 | Solid Support | NOVARTIS AG (CH) | 2025-07-24 | — | — | US | disclosed |
| US-12258680-B2 | Solid support | NOVARTIS AG (CH) | 2025-03-25 | — | — | US | disclosed |
| EP-3810570-B1 | SOLID SUPPORT | NOVARTIS AG (CH) | 2024-01-17 | — | — | EP | disclosed |
| US-20230160902-A1 | ZWITTERIONIC NANOPARTICLES | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E. V. (DE) | 2023-05-25 | — | — | US | disclosed |
| CN-114716874-B | Hydrophilic treatment-free plate protective adhesive and preparation method thereof | 安徽强邦新材料股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-114716874-A | Hydrophilic treatment-free plate protective adhesive and preparation method thereof | 安徽强邦新材料股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-112119056-A | Solid support | 诺华股份有限公司 | 2020-12-22 | — | — | CN | disclosed |
| WO-2020120970-A1 | METHODS FOR ENHANCING INDOCYANINE GREEN MEDICAL IMAGING AND PHOTOTHERAPY | NANOCO TECHNOLOGIES LTD (GB) | 2020-06-18 | — | — | WO | disclosed |
| EP-1759713-A2 | Lock and key micelles | UNIVERSITY OF SOUTH FLORIDA (US) | 2007-03-07 | — | — | EP | disclosed |
| US-4304721-A | Adrenergic blocking agents | HOFFMANN-LA ROCHE INC. (US) | 1981-12-08 | — | — | US | disclosed |
| US-4301300-A | ADRENERGIC BLOCKING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1981-11-17 | — | — | US | disclosed |
| US-4285873-A | ANTIANDROGENS | HOFFMANN-LA ROCHE INC. (US) | 1981-08-25 | — | — | US | disclosed |
| US-4281189-A | Sulfonamide intermediates for adrenergic blocking agents | HOFFMANN-LA ROCHE INC. (US) | 1981-07-28 | — | — | US | disclosed |
| US-4278608-A | Adrenergic blocking agents | HOFFMANN-LA ROCHE INC. (US) | 1981-07-14 | — | — | US | disclosed |
| US-4258185-A | HYPOTENSIVE, ANTITHROMBOTIC AGENTS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1981-03-24 | — | — | US | disclosed |
| US-4247710-A | THE 3'-HYDROXY, -BENZYLOXY, OR -HALO DERIVATIVES OF METHYL 4-((2'-HYDROXYPROPYL)OXY)PHENYLACETATE | HOFFMANN-LA ROCHE INC. (US) | 1981-01-27 | — | — | US | disclosed |
| US-4202978-A | ADRENERGIC BLOCKING AGENTS, HYPOTENSIVE, ANTISECRETORY, SPASMOLYTIC | HOFFMANN-LA ROCHE INC. (US) | 1980-05-13 | — | — | US | disclosed |
| EP-0005142-A1 | Phenylpiperazine derivatives, process for their preparation, intermediates for this purpose and medicaments containing such phenylpiperazine derivatives | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236990-A1 | Solid Support | POLM, POLH, POLI | KMT2A 1186/4885SOAT1 746/4885MEN1 3945/4885 |
| US-20230160902-A1 | ZWITTERIONIC NANOPARTICLES | ANXA3, ANXA5, ANXA11 | KMT2A 3703/4885SOAT1 1758/4885MEN1 846/4885 |
| US-12258680-B2 | Solid support | POLM, POLH, POLI | KMT2A 1186/4885SOAT1 746/4885MEN1 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.